Clear Street Markets LLC Abb Vie Inc. Call Options Transaction History

Clear Street Markets LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $1.45 Million - $1.67 Million	10,000 New	10,000 $1.59 Million
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $57,668 - $65,462	542 Added 216.8%	792 $8.54 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $2,104 - $2,344	-20 Reduced 7.41%	250 $2.82 Million
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $3,069 - $3,378	-30 Reduced 10.0%	270 $2.92 Million
Q4 2020 Feb 25, 2021	SELL	$80.49 - $108.67 $7,888 - $10,649	-98 Reduced 24.62%	300 $32,000
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $25,601 - $30,047	298 Added 298.0%	398 $3.49 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $25,800 - $39,116	-400 Reduced 80.0%	100 $762,000
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $12,596 - $15,144	-200 Reduced 28.57%	500 $3.79 Million
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $30,944 - $39,554	471 Added 205.68%	700 $5.09 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $15,995 - $20,431	229	229 $2.04 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.